Arsenal Medical, Inc.

Lyra Therapeutics, Inc.

480 Biomedical Inc.

Unilever Plc

Quynh P Pham

Upma Sharma

Changcheng You

Lee A Core

Jeffrey Groom, Ii

Nikhita Mansukhani

Craig Wiltsey

Courtney Guertin

Toby Freyman

Gregory T Zugates

Rany Busold

Danny Concagh

Adam Rago

Irina Gitlin

Jeffrey D Carbeck

Parisa Zamiri

Robert J Caulkins

John Marini

Xuri Yan

Robert F Mulligan

Stephen Roy Barrow

Michael Charles Cheney

Ross Paulson

Michele Chouinard

Danielle Peterson

Anthony Prostrollo

Jonathan Merlo

Abby N Picard

Changchen You

Alexander Lips

Brian John Dobkowski

Randall Beyreis

The present disclosure pertains to crosslinkable compositions and systems as well as methods for forming crosslinked compositions in situ, including the use of the same for embolizing vasculature including the neurovasculature within a patient, among many other uses.

Embolic compositions and methods

This disclosure describes various sinus scaffolds having fiber-based and non-fiber based designs, materials, devices, kits and methods that may be used to treat chronic sinusitis. These designs vary in form, dimension, and delivery location (i.e., maxillary, frontal, ethmoidal, sphenoidal sinuses, and middle meatus). In addition, therapeutic agent(s) may optionally be included within the scaffolds for local delivery over a brief or extended period of time.

Implantable scaffolds for treatment methods of sinusitus

This disclosure describes, inter alia, materials, devices, kits and methods that may be used to treat chronic sinusitis. The present disclosure describes various sinus scaffolds having fiber-based and non-fiber-based designs. These designs vary in form, dimension, and delivery location. In addition, therapeutic agent(s) may optionally be included within the scaffolds for local delivery over a brief or extended period of time. Therefore, these scaffolds may be used to improve sinus patency, for example, in surgically modified sinus spaces or in sinus spaces that have not previously undergone surgical modification. Moreover, these scaffolds may be used to deliver local therapeutic agent(s) to such sinus spaces, including, for instance, as part of a treatment program that is an alternative to sinus surgery (e.g., FESS) or in other instances as part of a postoperative care of FESS in some embodiments.

Implantable scaffolds for treatment of sinusitis

Systems and methods related to polymer foams are generally described. Some embodiments relate to compositions and methods for the preparation of polymer foams, and methods for using the polymer foams. The polymer foams can be applied to a body cavity and placed in contact with, for example, tissue, injured tissue, internal organs, etc. In some embodiments, the polymer foams can be formed within a body cavity (i.e., in situ foam formation). In addition, the foamed polymers may be capable of exerting a pressure on an internal surface of a body cavity and preventing or limiting movement of a bodily fluid (e.g., blood, etc.).

In situ forming hemostatic foam implants

Growing community of inventors

Methuen, MA, United States of America

Quynh P Pham